Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO01131) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
YC-1
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Preclinical/Patented Drug
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5712"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Induced by This Xenobiotics | ||||||
| Arachidonate 15-lipoxygenase (ALOX15) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. Cancer Res. 2005 Sep 15;65(18):8442-7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.